Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NEXIEN BIOPHARMA, INC. | Chief Financial Officer | Common stock | 6.5M | May 23, 2024 | Direct | ||
NEXIEN BIOPHARMA, INC. | Chief Financial Officer | Options to purchase common stock (right to buy) | 200K | May 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NXEN | NEXIEN BIOPHARMA, INC. | May 23, 2024 | 1 | $0 | 4 | May 28, 2024 | Chief Financial Officer |
NXEN | NEXIEN BIOPHARMA, INC. | Oct 31, 2023 | 1 | $0 | 4 | Nov 2, 2023 | Chief Financial Officer |
NXEN | NEXIEN BIOPHARMA, INC. | Jul 25, 2023 | 1 | $0 | 4 | Jul 31, 2023 | Chief Financial Officer |
NXEN | NEXIEN BIOPHARMA, INC. | Apr 1, 2023 | 1 | $0 | 4 | Apr 19, 2023 | Chief Financial Officer |
NXEN | NEXIEN BIOPHARMA, INC. | Jan 17, 2023 | 1 | $0 | 4 | Jan 17, 2023 | Chief Financial Officer |
NXEN | NEXIEN BIOPHARMA, INC. | Oct 17, 2022 | 1 | $0 | 4 | Oct 18, 2022 | Chief Financial Officer |
NXEN | NEXIEN BIOPHARMA, INC. | Apr 20, 2022 | 2 | $0 | 4 | Sep 14, 2022 | Chief Financial Officer |
NXEN | NEXIEN BIOPHARMA, INC. | Jan 27, 2022 | 1 | $0 | 4 | Jan 31, 2022 | Chief Financial Officer |
NXEN | NEXIEN BIOPHARMA, INC. | Nov 29, 2021 | 1 | $0 | 4 | Nov 29, 2021 | Chief Financial Officer |